These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25247344)

  • 1. Drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2014 Sep; 56(1452):91-6. PubMed ID: 25247344
    [No Abstract]   [Full Text] [Related]  

  • 2. Postmenopausal osteoporosis.
    Diab DL; Watts NB
    Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):501-9. PubMed ID: 24150190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future treatments of secondary osteoporosis.
    Soriano R; Herrera S; Nogués X; Diez-Perez A
    Best Pract Res Clin Endocrinol Metab; 2014 Dec; 28(6):885-94. PubMed ID: 25432359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of postmenopausal osteoporosis.
    Andreopoulou P; Bockman RS
    Annu Rev Med; 2015; 66():329-42. PubMed ID: 25386933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teriparitide update.
    Silverman SL; Nasser K
    Rheum Dis Clin North Am; 2011 Aug; 37(3):471-7, vii. PubMed ID: 22023903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Pharmacologic Therapy in Postmenopausal Osteoporosis.
    Shen Y; Gray DL; Martinez DS
    Endocrinol Metab Clin North Am; 2017 Mar; 46(1):193-206. PubMed ID: 28131133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Denosumab, osteoporosis, and prevention of fractures.
    Kyrgidis A
    N Engl J Med; 2009 Nov; 361(22):2189; author reply 2190-1. PubMed ID: 19950409
    [No Abstract]   [Full Text] [Related]  

  • 8. Ask the doctor. I'm looking for information on Prolia and Reclast as alternatives to Boniva.
    Robb-Nicholson C
    Harv Womens Health Watch; 2011 Nov; 19(3):8. PubMed ID: 22276325
    [No Abstract]   [Full Text] [Related]  

  • 9. [Teriparatide--new value in osteoporosis treatment: treatment guidelines].
    Korsić M; Kastelan D
    Reumatizam; 2006; 53(2):77-81. PubMed ID: 17580560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.
    Palacios S; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Schenck-Gustafsson K; Tremollieres F; Vujovic S; Rees M; Rozenberg S
    Maturitas; 2012 Feb; 71(2):194-8. PubMed ID: 22176952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs for postmenopausal osteoporosis.
    Treat Guidel Med Lett; 2008 Oct; 6(74):67-74; quiz 75-6. PubMed ID: 18800025
    [No Abstract]   [Full Text] [Related]  

  • 12. New therapeutical horizons in the management of postmenopausal osteoporosis.
    Migliaccio S; Fornari R; Greco EA; Di Luigi L; Lenzi A
    Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S117-9. PubMed ID: 24048905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis.
    Josse R; Khan A; Ngui D; Shapiro M
    Curr Med Res Opin; 2013 Mar; 29(3):205-16. PubMed ID: 23297819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New developments in the treatment of osteoporosis.
    Eriksen EF; Halse J; Moen MH
    Acta Obstet Gynecol Scand; 2013 Jun; 92(6):620-36. PubMed ID: 22646526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary success with combination treatment for osteoporosis.
    BMJ; 2013 May; 346():f3221. PubMed ID: 23699634
    [No Abstract]   [Full Text] [Related]  

  • 16. [The influence of teriparatide (Forteo) on low back pain incidence in postmenopausal osteoporotic woman].
    Vlak T; Labar L; Sapina G; Novak A; Sabić M
    Reumatizam; 2007; 54(2):93-5. PubMed ID: 18351155
    [No Abstract]   [Full Text] [Related]  

  • 17. Denosumab is an option for treatment of osteoporosis.
    Simonelli C
    Am Fam Physician; 2012 Dec; 86(11):992; author reply 994. PubMed ID: 23198660
    [No Abstract]   [Full Text] [Related]  

  • 18. Postmenopausal women with osteoporosis: experience when treated with teriparatide in clinical practice.
    Ish-Shalom S; Dumitrache C; El-Husseini TF; Hussein A; Barker C; Pavo I
    Curr Med Res Opin; 2011 Feb; 27(2):343-53. PubMed ID: 21166609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of SERMs on bone health. The effects of raloxifene on bone quality evaluated by hip structure analysis].
    Takada J; Iba K; Yamashita T; Yoshizaki T
    Clin Calcium; 2010 Mar; 20(3):355-63. PubMed ID: 20190365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteonecrosis of the jaw after osteoporosis therapy with denosumab following long-term bisphosphonate therapy.
    Rachner TD; Platzbecker U; Felsenberg D; Hofbauer LC
    Mayo Clin Proc; 2013 Apr; 88(4):418-9. PubMed ID: 23541016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.